Model Number D134805 |
Device Problem
Patient Device Interaction Problem (4001)
|
Patient Problem
Cardiac Arrest (1762)
|
Event Date 03/06/2023 |
Event Type
Injury
|
Event Description
|
It was reported that a patient underwent an afib ¿ paroxysmal ablation procedure with a thermocool® smart touch® sf bi-directional navigation catheter.The patient suffered a cardiac arrest.It was reported that during a paf ( paroxysmal afib) procedure , there was administration of isp (isoproterenol) and atp ( adenosine triphosphate) at induction after pvi (pulmonary vein isolation) and ct ( computed tomography)at the first administration of atp, af ( atrial fibrillation) occurred and stopped spontaneously.Transition from af onset to vt ( ventricular tachycardia) and then vf ( ventricular fibrillation ) at the second administration of atp.Cardioversion was performed 5 times but did not return to sr ( sinus rhythm).Proceeded to cpr including cardiac massage and extracorporeal membrane oxygenation (ecmo) placement.Timing when complaints occurred was after completion of all treatments at about 200 minutes after entering the room and after administration of the second isp and atp as the last induction.Circulatory failure due to vt and vf.Ecmo (extracorporeal membrane oxygenation ) and iabp (intra-aortic balloon pump ) insertion were performed.The physician's opinions on the relationship between the event and the product was that there was no relationship with the product.There were no abnormalities observed prior to and during use of the product.[relevant medical history]: medical history: omi, vt present.Pci and cabg were implanted for omi; icd was implanted for vt." the soundstar catheter is not from sterilmed.This adverse event discovered post use of biosense webster products.Patient did require extended hospitalization because of the adverse event.No products will be returned.Additional information- -the catheter is not from sterilmed.They tried to obtain lot number information, but we were unable to obtain the information because no record was kept.Additional information- this adverse event was discovered during use of biosense webster products.Physician¿s opinion on the cause of this adverse event was not related with the bw product; due to procedure; induction by administration of isp(isoproterenol).The patient has not been recovered yet.The patient was disengaged from ecmo and regained consciousness, but left hemiparesis was present.Hospitalization was extended due to observation for residual sequelae.Relevant tests/laboratory data --- nothing in particular.Smartablate generator was used, the serial number was unknown.Since the event is life threatening and it might result in permanent impairment of a body function or permanent damage to a body structure; or it could require medical or surgical intervention to prevent permanent impairment of a body function or permanent damage to a body structure, it is to be considered serious and mdr-reportable.
|
|
Manufacturer Narrative
|
Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc.Or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Manufacturer Narrative
|
On 25-may-2023, the product investigation was updated to include the manufacturing record evaluation.A manufacturing record evaluation was performed for the finished device number lot 30949217l and no internal action related to the complaint was found during the review.The manufacture date (1-dec-2022) and expiration date (30-nov-2025) were updated accordingly."analysis of production records" code was added to the h6 type of investigation.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
|
|
Search Alerts/Recalls
|
|